Ferroptosis and cellular senescence -Related Genes in Cervical Cancer: Mechanistic Insights from Multi-Omics and Clinical Sample Analysis
•Ferroptosis and aging have serious effects on human tumors.•The GSVA scores of ferroptosis and aging are upregulated in cervical cancer tissues.•Ferroptosis and aging score related genes in different data sets can effectively predict the prognosis of cervical cancer patients.•Verification of abnorm...
Saved in:
| Published in | Translational oncology Vol. 60; p. 102487 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.10.2025
Neoplasia Press Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | •Ferroptosis and aging have serious effects on human tumors.•The GSVA scores of ferroptosis and aging are upregulated in cervical cancer tissues.•Ferroptosis and aging score related genes in different data sets can effectively predict the prognosis of cervical cancer patients.•Verification of abnormal expression of ferroptosis and aging score related genes in cervical cancer by multiple experiments.
Mortality and treatment failure in cervical cancer (CC) patients are primarily due to extensive metastasis and chemoresistance. Immunotherapy has emerged as a crucial clinical treatment strategy for CC patients; however, the current methods and biomarkers are inadequate for accurately predicting immunotherapy responses and patient prognosis. This study comprehensively analyzed ferroptosis and cellular senescence, two processes intricately linked to tumorigenesis, progression, and therapy, utilizing multi-omics data from TCGA-CESC, GEO cohorts, and clinical data from CC patients. Based on ferroptosis- and cellular senescence -related patterns, two distinct clusters with divergent prognoses and tumor microenvironment (TME) characteristics were identified. A prognostic model was subsequntly constructed, demonstrating robust reliability in predicting CC prognosis and response to immunotherapy. Patients in the low-risk group exhibited enriched immune cell infiltration, lower TIDE scores, higher IPS scores, and higher expression levels of immune checkpoint inhibitor-related genes, such as PDCD1 and CTLA4, which were associated with improved overall outcomes. Validation with clinical samples confirmed the differential expression of model-associated genes in CC, further supporting the model's accuracy. This prognostic model provides valuable insights into predicting CC prognosis and optimizing immunotherapy, offering potential benefits for personalized treatment strategies.
[Display omitted] |
|---|---|
| AbstractList | •Ferroptosis and aging have serious effects on human tumors.•The GSVA scores of ferroptosis and aging are upregulated in cervical cancer tissues.•Ferroptosis and aging score related genes in different data sets can effectively predict the prognosis of cervical cancer patients.•Verification of abnormal expression of ferroptosis and aging score related genes in cervical cancer by multiple experiments.
Mortality and treatment failure in cervical cancer (CC) patients are primarily due to extensive metastasis and chemoresistance. Immunotherapy has emerged as a crucial clinical treatment strategy for CC patients; however, the current methods and biomarkers are inadequate for accurately predicting immunotherapy responses and patient prognosis. This study comprehensively analyzed ferroptosis and cellular senescence, two processes intricately linked to tumorigenesis, progression, and therapy, utilizing multi-omics data from TCGA-CESC, GEO cohorts, and clinical data from CC patients. Based on ferroptosis- and cellular senescence -related patterns, two distinct clusters with divergent prognoses and tumor microenvironment (TME) characteristics were identified. A prognostic model was subsequntly constructed, demonstrating robust reliability in predicting CC prognosis and response to immunotherapy. Patients in the low-risk group exhibited enriched immune cell infiltration, lower TIDE scores, higher IPS scores, and higher expression levels of immune checkpoint inhibitor-related genes, such as PDCD1 and CTLA4, which were associated with improved overall outcomes. Validation with clinical samples confirmed the differential expression of model-associated genes in CC, further supporting the model's accuracy. This prognostic model provides valuable insights into predicting CC prognosis and optimizing immunotherapy, offering potential benefits for personalized treatment strategies.
[Display omitted] Mortality and treatment failure in cervical cancer (CC) patients are primarily due to extensive metastasis and chemoresistance. Immunotherapy has emerged as a crucial clinical treatment strategy for CC patients; however, the current methods and biomarkers are inadequate for accurately predicting immunotherapy responses and patient prognosis. This study comprehensively analyzed ferroptosis and cellular senescence, two processes intricately linked to tumorigenesis, progression, and therapy, utilizing multi-omics data from TCGA-CESC, GEO cohorts, and clinical data from CC patients. Based on ferroptosis- and cellular senescence -related patterns, two distinct clusters with divergent prognoses and tumor microenvironment (TME) characteristics were identified. A prognostic model was subsequntly constructed, demonstrating robust reliability in predicting CC prognosis and response to immunotherapy. Patients in the low-risk group exhibited enriched immune cell infiltration, lower TIDE scores, higher IPS scores, and higher expression levels of immune checkpoint inhibitor-related genes, such as PDCD1 and CTLA4, which were associated with improved overall outcomes. Validation with clinical samples confirmed the differential expression of model-associated genes in CC, further supporting the model's accuracy. This prognostic model provides valuable insights into predicting CC prognosis and optimizing immunotherapy, offering potential benefits for personalized treatment strategies. Mortality and treatment failure in cervical cancer (CC) patients are primarily due to extensive metastasis and chemoresistance. Immunotherapy has emerged as a crucial clinical treatment strategy for CC patients; however, the current methods and biomarkers are inadequate for accurately predicting immunotherapy responses and patient prognosis. This study comprehensively analyzed ferroptosis and cellular senescence, two processes intricately linked to tumorigenesis, progression, and therapy, utilizing multi-omics data from TCGA-CESC, GEO cohorts, and clinical data from CC patients. Based on ferroptosis- and cellular senescence -related patterns, two distinct clusters with divergent prognoses and tumor microenvironment (TME) characteristics were identified. A prognostic model was subsequntly constructed, demonstrating robust reliability in predicting CC prognosis and response to immunotherapy. Patients in the low-risk group exhibited enriched immune cell infiltration, lower TIDE scores, higher IPS scores, and higher expression levels of immune checkpoint inhibitor-related genes, such as PDCD1 and CTLA4, which were associated with improved overall outcomes. Validation with clinical samples confirmed the differential expression of model-associated genes in CC, further supporting the model's accuracy. This prognostic model provides valuable insights into predicting CC prognosis and optimizing immunotherapy, offering potential benefits for personalized treatment strategies.Mortality and treatment failure in cervical cancer (CC) patients are primarily due to extensive metastasis and chemoresistance. Immunotherapy has emerged as a crucial clinical treatment strategy for CC patients; however, the current methods and biomarkers are inadequate for accurately predicting immunotherapy responses and patient prognosis. This study comprehensively analyzed ferroptosis and cellular senescence, two processes intricately linked to tumorigenesis, progression, and therapy, utilizing multi-omics data from TCGA-CESC, GEO cohorts, and clinical data from CC patients. Based on ferroptosis- and cellular senescence -related patterns, two distinct clusters with divergent prognoses and tumor microenvironment (TME) characteristics were identified. A prognostic model was subsequntly constructed, demonstrating robust reliability in predicting CC prognosis and response to immunotherapy. Patients in the low-risk group exhibited enriched immune cell infiltration, lower TIDE scores, higher IPS scores, and higher expression levels of immune checkpoint inhibitor-related genes, such as PDCD1 and CTLA4, which were associated with improved overall outcomes. Validation with clinical samples confirmed the differential expression of model-associated genes in CC, further supporting the model's accuracy. This prognostic model provides valuable insights into predicting CC prognosis and optimizing immunotherapy, offering potential benefits for personalized treatment strategies. • Ferroptosis and aging have serious effects on human tumors. • The GSVA scores of ferroptosis and aging are upregulated in cervical cancer tissues. • Ferroptosis and aging score related genes in different data sets can effectively predict the prognosis of cervical cancer patients. • Verification of abnormal expression of ferroptosis and aging score related genes in cervical cancer by multiple experiments. Mortality and treatment failure in cervical cancer (CC) patients are primarily due to extensive metastasis and chemoresistance. Immunotherapy has emerged as a crucial clinical treatment strategy for CC patients; however, the current methods and biomarkers are inadequate for accurately predicting immunotherapy responses and patient prognosis. This study comprehensively analyzed ferroptosis and cellular senescence, two processes intricately linked to tumorigenesis, progression, and therapy, utilizing multi-omics data from TCGA-CESC, GEO cohorts, and clinical data from CC patients. Based on ferroptosis- and cellular senescence -related patterns, two distinct clusters with divergent prognoses and tumor microenvironment (TME) characteristics were identified. A prognostic model was subsequntly constructed, demonstrating robust reliability in predicting CC prognosis and response to immunotherapy. Patients in the low-risk group exhibited enriched immune cell infiltration, lower TIDE scores, higher IPS scores, and higher expression levels of immune checkpoint inhibitor-related genes, such as PDCD1 and CTLA4, which were associated with improved overall outcomes. Validation with clinical samples confirmed the differential expression of model-associated genes in CC, further supporting the model's accuracy. This prognostic model provides valuable insights into predicting CC prognosis and optimizing immunotherapy, offering potential benefits for personalized treatment strategies. Image, graphical abstract |
| ArticleNumber | 102487 |
| Author | Luo, Yongjin Tang, Lihua Yang, Yihua Trang, DinhHuyen Mo, Dan Zeng, Zhonghong |
| Author_xml | – sequence: 1 givenname: Yongjin surname: Luo fullname: Luo, Yongjin organization: Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China – sequence: 2 givenname: Lihua surname: Tang fullname: Tang, Lihua organization: Nanning Second People's Hospital, Nanning, 530021, China – sequence: 3 givenname: Zhonghong surname: Zeng fullname: Zeng, Zhonghong organization: Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China – sequence: 4 givenname: DinhHuyen orcidid: 0009-0007-6201-4669 surname: Trang fullname: Trang, DinhHuyen organization: Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China – sequence: 5 givenname: Dan surname: Mo fullname: Mo, Dan email: 2280985880@qq.com organization: Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China – sequence: 6 givenname: Yihua surname: Yang fullname: Yang, Yihua email: workyyh@163.com organization: Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40784206$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFUstu3CAUtapUzaP9g6pi2Y0nGGxsV1WraNQkIyWK1McaAb7MMMUwAc9I8wn96-J4GiXdZAW6nIe455xmR847yLL3BZ4VuGDn69kQRJrNCCZVGpGyqV9lJ0VLWV4RSo-e3I-z0xjXGLOiJeRNdlziuikJZifZn0sIwW8GH01EwnVIgbVbKwKK4CAqcApQ_h2sGKBDV-MMGYfmEHZGCYvmIgHCJ3QLaiWciYNRaOGiWa6GiHTwPbrd2sHkd71Rk8HcGvdA_SH6jQV04YTdJ_e32WstbIR3h_Ms-3X57ef8Or-5u1rML25yVZZtnUtZSaU00bjShDGtqJSaFU1VKVwXhIgqvQrFVKWxaKEDBnVFJZENFKWkHT3LFpNu58Wab4LpRdhzLwx_GPiw5CKkb1jglCoJrFWd1FDSggldQ91J0pCuZLhuk9bXSWuzlT10aVspE_tM9PmLMyu-9DteEFrVhI0KHw8Kwd9vIQ68N3HMQDjw28gpoSmppmFNgn54avbo8i_MBCgngAo-xgD6EVJgPnaGr_nUGT52hk-dSbQvEw3S1ncGAo_KjLl3JoAa0lrMSwKf_xNQh4x_w_5l-l-Fr-Oh |
| Cites_doi | 10.21037/atm-20-2554a 10.1126/scitranslmed.aaa7161 10.1007/s12094-020-02409-4 10.3390/nu16040496 10.1016/j.yexmp.2019.02.001 10.1155/2017/8913860 10.21037/atm-21-6265 10.2147/CMAR.S456548 10.1016/j.biopha.2020.110108 10.1016/j.ygyno.2021.08.018 10.1038/ni1102-991 10.1038/nature14344 10.2174/1568009611313020009 10.3389/fmolb.2023.1216733 10.1038/nature04870 10.1016/j.ygeno.2020.10.036 10.1007/s11864-020-00790-4 10.3892/or.2022.8288 10.1016/S0140-6736(18)32470-X 10.3802/jgo.2016.27.e43 10.1186/s12935-021-01867-2 10.1002/hep.28251 10.1016/j.cell.2011.02.013 10.1186/s12920-021-00885-3 10.1038/s41590-017-0006-x 10.1038/s41467-019-13601-8 10.1016/j.cmet.2015.12.006 10.1016/j.ejso.2015.12.014 10.1038/s41577-021-00574-3 10.1002/jcp.24808 10.1073/pnas.1720948115 10.1016/j.lfs.2020.117863 10.21037/tcr-22-292 10.1002/kjm2.12182 10.1002/jcp.29232 10.1126/sciadv.add8977 10.1038/s41523-020-0161-3 10.1038/s41419-022-04576-4 10.1016/j.celrep.2016.12.019 10.1038/s41418-020-00616-8 10.1038/s41467-018-07195-w 10.1126/science.1178331 10.1038/s41419-024-06544-6 10.1016/S0140-6736(00)04046-0 10.1016/j.cell.2022.06.003 10.1007/s13238-021-00841-y 10.1126/science.1203486 10.1111/cas.13874 10.1038/s41565-019-0406-1 10.1097/CM9.0000000000002108 10.1016/j.ygyno.2015.06.009 10.3390/ijms24032606 10.1038/cddis.2016.208 10.1080/17460441.2018.1443074 10.4143/crt.2016.572 10.1016/j.ccell.2019.04.002 10.1016/S0140-6736(12)60209-8 10.1158/0008-5472.CAN-07-2282 10.1016/S0140-6736(20)30366-4 10.1186/s12935-020-01292-x 10.1097/01.mpa.0000153326.69816.7d 10.1186/s13059-016-1070-5 10.1101/cshperspect.a031435 10.1038/s41568-019-0149-1 10.1097/JXX.0000000000000579 10.1186/s12943-022-01530-y 10.2147/CIA.S158513 10.1038/s41591-018-0136-1 10.1007/s00262-020-02628-2 |
| ContentType | Journal Article |
| Copyright | 2025 Copyright © 2025. Published by Elsevier Inc. 2025 Published by Elsevier Inc. 2025 |
| Copyright_xml | – notice: 2025 – notice: Copyright © 2025. Published by Elsevier Inc. – notice: 2025 Published by Elsevier Inc. 2025 |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1016/j.tranon.2025.102487 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1936-5233 |
| ExternalDocumentID | oai_doaj_org_article_33cbe69cdbfe4316af7e7db282d46079 PMC12357269 40784206 10_1016_j_tranon_2025_102487 S1936523325002189 |
| Genre | Journal Article |
| GroupedDBID | --- .1- .FO 0R~ 1P~ 29Q 2WC 4.4 457 53G 5VS AAEDT AAEDW AAIKJ AAKDD AALRI AAXUO AAYWO ABMAC ACGFS ACVFH ADBBV ADCNI ADEZE ADVLN AENEX AEUPX AEVXI AEXQZ AFJKZ AFPUW AFRHN AFTJW AGHFR AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS APXCP BAWUL BCNDV DIK E3Z EBS EJD F5P FDB GROUPED_DOAJ GX1 HYE IPNFZ IXB KQ8 OC~ OK1 OO- RIG ROL RPM SSZ TR2 Z5R 6I. AAFTH AAYXX CITATION NPM 7X8 AFCTW 5PM |
| ID | FETCH-LOGICAL-c4497-bb5bccf2f05f266fc3bbf61855c07122a5ccfac6c5f0a9ede6e753b2b8e14b3d3 |
| IEDL.DBID | DOA |
| ISSN | 1936-5233 |
| IngestDate | Wed Aug 27 01:00:55 EDT 2025 Thu Aug 21 18:24:47 EDT 2025 Mon Aug 11 17:31:20 EDT 2025 Thu Aug 28 04:49:23 EDT 2025 Wed Aug 27 16:38:47 EDT 2025 Sat Aug 30 17:14:27 EDT 2025 Tue Aug 26 16:32:53 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Ferroptosis Immunotherapy Cervical cancer Cellular senescence |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. Copyright © 2025. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4497-bb5bccf2f05f266fc3bbf61855c07122a5ccfac6c5f0a9ede6e753b2b8e14b3d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work |
| ORCID | 0009-0007-6201-4669 |
| OpenAccessLink | https://doaj.org/article/33cbe69cdbfe4316af7e7db282d46079 |
| PMID | 40784206 |
| PQID | 3238428868 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_33cbe69cdbfe4316af7e7db282d46079 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12357269 proquest_miscellaneous_3238428868 pubmed_primary_40784206 crossref_primary_10_1016_j_tranon_2025_102487 elsevier_sciencedirect_doi_10_1016_j_tranon_2025_102487 elsevier_clinicalkey_doi_10_1016_j_tranon_2025_102487 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-10-01 |
| PublicationDateYYYYMMDD | 2025-10-01 |
| PublicationDate_xml | – month: 10 year: 2025 text: 2025-10-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Translational oncology |
| PublicationTitleAlternate | Transl Oncol |
| PublicationYear | 2025 |
| Publisher | Elsevier Inc Neoplasia Press Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Neoplasia Press – name: Elsevier |
| References | Shazly, Murad, Dowdy (bib0003) 2015; 138 Cohen, P.A., A. Jhingran, A. Oaknin, et al., Cerv. Cancer. Lancet, 2019. 393(10167): p. 169–182. Chen, Qiu, Zeng (bib0040) 2021; 21 Guo, Xu, Han (bib0009) 2018; 50 Jin, Zhu, Chen (bib0049) 2024 Zhang, Liu, Jin (bib0017) 2022; 21 Jones, Anagnostou, Lytle (bib0027) 2015; 7 Sehl, Carroll, Horvath (bib0069) 2020; 6 Schreiber, Old, Smyth (bib0031) 2011; 331 Hanahan, Weinberg (bib0032) 2011; 144 Geissmann, Manz, Jung (bib0074) 2010; 327 Buskwofie, David-West, Clare (bib0064) 2020; 112 Kurpinska, Suraj, Bonar (bib0061) 2019; 107 Jiang, Gu, Pan (bib0080) 2018; 24 <enhanced citrate synthase activity i source pancreas so 2005 mar 30 2 99 104.pdf>. Sun, Chen, Zhai (bib0026) 2020; 127 Luan, Zhang, Xie (bib0062) 2021; 23 Xia, Dong, Li (bib0038) 2022; 135 Li, Chang, Tsang (bib0045) 2022 Qin, Liao, Du (bib0056) 2020; 20 <tumor-derived tgf-β inhibits mitochondrial respiration to suppress ifn-γ production by human.pdf>. Beretta, Zaffaroni (bib0021) 2023; 10 Liguori, Russo, Curcio (bib0024) 2018; 13 Song, Yao, Xia (bib0057) 2024; 16 Yang, Yin, Liu (bib0044) 2022; 10 Becht, Giraldo, Lacroix (bib0079) 2016; 17 Fu, Yu (bib0055) 2020; 256 Li, Wang, Dang (bib0076) 2022; 11 Huang, Yang, Lu (bib0005) 2021; 28 Liu, Zhang, Yan (bib0037) 2023; 9 Dai, Pei, Zhu (bib0071) 2024; 5 Jiang, Kon, Li (bib0015) 2015; 520 Wolford, Tewari (bib0006) 2018; 13 Zhang, Sui, Wang (bib0020) 2020; 235 Dominguez, Veronese, Barbagallo (bib0028) 2024; 16 Tsukamoto, Imai, Ishimoto (bib0073) 2019; 110 Sert, Boggess, Ahmad (bib0002) 2016; 42 Tang, Hua, Xu (bib0008) 2020; 8 Friedmann Angeli, Krysko, Conrad (bib0018) 2019; 19 Hassannia, Vandenabeele, Vanden Berghe (bib0023) 2019; 35 Zhou, Li (bib0058) 2020; 36 Han, Wang, Lv (bib0043) 2023 Wysocki (bib0025) 2021; 33 Philip, Schietinger (bib0067) 2022; 22 Montes, Chapoval, Nelson (bib0070) 2008; 68 Chelakkot, Chelakkot, Shin (bib0051) 2023; 24 Chen, Hao, Liu (bib0050) 2023 He, Wang, Lu (bib0054) 2022; 13 Liu, Chen, Wang (bib0053) 2024; 15 Ma, Henson, Chen (bib0010) 2016; 7 Rotondo, Bosi, Bassi (bib0047) 2015; 230 Yamaguchi, Kasukabe, Kumakura (bib0012) 2018; 52 Jin, Fan, Long (bib0016) 2024 Waters, Der (bib0019) 2018; 8 Stockwell (bib0014) 2022; 185 Karin (bib0034) 2006; 441 Peranzoni, Lemoine, Vimeux (bib0075) 2018; 115 Komura, Mabuchi, Shimura (bib0078) 2020; 69 Trujillo-Alonso, Pratt, Zong (bib0011) 2019; 14 Compte, Harwood, Munoz (bib0065) 2018; 9 O'Malley, Oaknin, Monk (bib0066) 2021; 163 Pavlova, Thompson (bib0059) 2016; 23 Chitsike, Duerksen-Hughes (bib0007) 2020; 21 Tominaga, Suzuki (bib0068) 2019 Charoentong, Finotello, Angelova (bib0081) 2017; 18 Mehta, Mooij, Brankovic (bib0048) 2017; 2017 Qin, Cao, Ye (bib0041) 2021; 14 Sun, Ou, Chen (bib0013) 2016; 63 <a cellular senescence related genes source aging albany ny so 2023.pdf>. Nie, Ju, Fan (bib0052) 2020; 11 Rao, Zhang, Kobetz (bib0042) 2021; 113 Nikolich-Zugich (bib0029) 2018; 19 Li, Wu, Cheng (bib0039) 2016; 27 Zhang, Wang, Hu (bib0063) 2022; 47 Yee, de Souza, Khachigian (bib0004) 2013; 13 Rothwell, Wilson, Price (bib0035) 2012; 379 Lei, Mao, Yan (bib0022) 2021; 12 Dunn, Bruce, Ikeda (bib0030) 2002; 3 Liu, Si, Bagley (bib0072) 2022 Balkwill, Mantovani (bib0033) 2001; 357 Burn, Sheth, Elliott (bib0036) 2020; 395 Beretta (10.1016/j.tranon.2025.102487_bib0021) 2023; 10 Li (10.1016/j.tranon.2025.102487_bib0045) 2022 Zhou (10.1016/j.tranon.2025.102487_bib0058) 2020; 36 Komura (10.1016/j.tranon.2025.102487_bib0078) 2020; 69 Song (10.1016/j.tranon.2025.102487_bib0057) 2024; 16 Zhang (10.1016/j.tranon.2025.102487_bib0063) 2022; 47 Buskwofie (10.1016/j.tranon.2025.102487_bib0064) 2020; 112 Li (10.1016/j.tranon.2025.102487_bib0076) 2022; 11 Waters (10.1016/j.tranon.2025.102487_bib0019) 2018; 8 Yang (10.1016/j.tranon.2025.102487_bib0044) 2022; 10 Pavlova (10.1016/j.tranon.2025.102487_bib0059) 2016; 23 Qin (10.1016/j.tranon.2025.102487_bib0056) 2020; 20 Zhang (10.1016/j.tranon.2025.102487_bib0020) 2020; 235 Luan (10.1016/j.tranon.2025.102487_bib0062) 2021; 23 Charoentong (10.1016/j.tranon.2025.102487_bib0081) 2017; 18 Wysocki (10.1016/j.tranon.2025.102487_bib0025) 2021; 33 Sert (10.1016/j.tranon.2025.102487_bib0002) 2016; 42 Hassannia (10.1016/j.tranon.2025.102487_bib0023) 2019; 35 Becht (10.1016/j.tranon.2025.102487_bib0079) 2016; 17 Shazly (10.1016/j.tranon.2025.102487_bib0003) 2015; 138 Ma (10.1016/j.tranon.2025.102487_bib0010) 2016; 7 Stockwell (10.1016/j.tranon.2025.102487_bib0014) 2022; 185 Jiang (10.1016/j.tranon.2025.102487_bib0080) 2018; 24 Rao (10.1016/j.tranon.2025.102487_bib0042) 2021; 113 Guo (10.1016/j.tranon.2025.102487_bib0009) 2018; 50 Xia (10.1016/j.tranon.2025.102487_bib0038) 2022; 135 Kurpinska (10.1016/j.tranon.2025.102487_bib0061) 2019; 107 Dai (10.1016/j.tranon.2025.102487_bib0071) 2024; 5 Nie (10.1016/j.tranon.2025.102487_bib0052) 2020; 11 Hanahan (10.1016/j.tranon.2025.102487_bib0032) 2011; 144 Tominaga (10.1016/j.tranon.2025.102487_bib0068) 2019 Peranzoni (10.1016/j.tranon.2025.102487_bib0075) 2018; 115 O'Malley (10.1016/j.tranon.2025.102487_bib0066) 2021; 163 Yee (10.1016/j.tranon.2025.102487_bib0004) 2013; 13 Qin (10.1016/j.tranon.2025.102487_bib0041) 2021; 14 Liu (10.1016/j.tranon.2025.102487_bib0053) 2024; 15 Burn (10.1016/j.tranon.2025.102487_bib0036) 2020; 395 10.1016/j.tranon.2025.102487_bib0060 Tsukamoto (10.1016/j.tranon.2025.102487_bib0073) 2019; 110 Trujillo-Alonso (10.1016/j.tranon.2025.102487_bib0011) 2019; 14 Dunn (10.1016/j.tranon.2025.102487_bib0030) 2002; 3 Liu (10.1016/j.tranon.2025.102487_bib0037) 2023; 9 Nikolich-Zugich (10.1016/j.tranon.2025.102487_bib0029) 2018; 19 Yamaguchi (10.1016/j.tranon.2025.102487_bib0012) 2018; 52 Liguori (10.1016/j.tranon.2025.102487_bib0024) 2018; 13 Liu (10.1016/j.tranon.2025.102487_bib0072) 2022 Chitsike (10.1016/j.tranon.2025.102487_bib0007) 2020; 21 Mehta (10.1016/j.tranon.2025.102487_bib0048) 2017; 2017 He (10.1016/j.tranon.2025.102487_bib0054) 2022; 13 Rotondo (10.1016/j.tranon.2025.102487_bib0047) 2015; 230 Sun (10.1016/j.tranon.2025.102487_bib0026) 2020; 127 Schreiber (10.1016/j.tranon.2025.102487_bib0031) 2011; 331 Jiang (10.1016/j.tranon.2025.102487_bib0015) 2015; 520 Jin (10.1016/j.tranon.2025.102487_bib0049) 2024 Zhang (10.1016/j.tranon.2025.102487_bib0017) 2022; 21 Dominguez (10.1016/j.tranon.2025.102487_bib0028) 2024; 16 10.1016/j.tranon.2025.102487_bib0046 10.1016/j.tranon.2025.102487_bib0001 Han (10.1016/j.tranon.2025.102487_bib0043) 2023 Friedmann Angeli (10.1016/j.tranon.2025.102487_bib0018) 2019; 19 Montes (10.1016/j.tranon.2025.102487_bib0070) 2008; 68 Wolford (10.1016/j.tranon.2025.102487_bib0006) 2018; 13 Fu (10.1016/j.tranon.2025.102487_bib0055) 2020; 256 Compte (10.1016/j.tranon.2025.102487_bib0065) 2018; 9 Huang (10.1016/j.tranon.2025.102487_bib0005) 2021; 28 Sehl (10.1016/j.tranon.2025.102487_bib0069) 2020; 6 Philip (10.1016/j.tranon.2025.102487_bib0067) 2022; 22 Rothwell (10.1016/j.tranon.2025.102487_bib0035) 2012; 379 Li (10.1016/j.tranon.2025.102487_bib0039) 2016; 27 Tang (10.1016/j.tranon.2025.102487_bib0008) 2020; 8 Chelakkot (10.1016/j.tranon.2025.102487_bib0051) 2023; 24 Sun (10.1016/j.tranon.2025.102487_bib0013) 2016; 63 Geissmann (10.1016/j.tranon.2025.102487_bib0074) 2010; 327 Chen (10.1016/j.tranon.2025.102487_bib0040) 2021; 21 Chen (10.1016/j.tranon.2025.102487_bib0050) 2023 10.1016/j.tranon.2025.102487_bib0077 Jin (10.1016/j.tranon.2025.102487_bib0016) 2024 Jones (10.1016/j.tranon.2025.102487_bib0027) 2015; 7 Lei (10.1016/j.tranon.2025.102487_bib0022) 2021; 12 Balkwill (10.1016/j.tranon.2025.102487_bib0033) 2001; 357 Karin (10.1016/j.tranon.2025.102487_bib0034) 2006; 441 |
| References_xml | – volume: 47 year: 2022 ident: bib0063 article-title: Inhibition of LDHA suppresses cell proliferation and increases mitochondrial apoptosis via the JNK signaling pathway in cervical cancer cells publication-title: Oncol. Rep. – volume: 69 start-page: 2477 year: 2020 end-page: 2499 ident: bib0078 article-title: The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer publication-title: Cancer Immunol. Immunther. – volume: 13 start-page: 757 year: 2018 end-page: 772 ident: bib0024 article-title: Oxidative stress, aging, and diseases publication-title: Clin. Interv. Aging – volume: 331 start-page: 1565 year: 2011 end-page: 1570 ident: bib0031 article-title: Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion publication-title: Science – volume: 42 start-page: 513 year: 2016 end-page: 522 ident: bib0002 article-title: Robot-assisted versus open radical hysterectomy: a multi-institutional experience for early-stage cervical cancer publication-title: Eur. J. Surg. Oncol. – volume: 107 start-page: 129 year: 2019 end-page: 140 ident: bib0061 article-title: Proteomic characterization of early lung response to breast cancer metastasis in mice publication-title: Exp. Mol. Pathol. – reference: <tumor-derived tgf-β inhibits mitochondrial respiration to suppress ifn-γ production by human.pdf>. – volume: 52 start-page: 1011 year: 2018 end-page: 1022 ident: bib0012 article-title: Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis publication-title: Int. J. Oncol. – volume: 16 year: 2024 ident: bib0028 article-title: Magnesium and the hallmarks of aging publication-title: Nutrients. – start-page: 10 year: 2022 ident: bib0072 article-title: Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy publication-title: J. ImmunOther Cancer – volume: 357 start-page: 539 year: 2001 end-page: 545 ident: bib0033 article-title: Inflammation and cancer: back to Virchow? publication-title: Lancet – volume: 21 start-page: 182 year: 2021 ident: bib0040 article-title: Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis publication-title: Cancer Cell Int. – volume: 127 year: 2020 ident: bib0026 article-title: The emerging role of ferroptosis in inflammation publication-title: Biomed. PharmacOther – reference: <enhanced citrate synthase activity i source pancreas so 2005 mar 30 2 99 104.pdf>. – volume: 256 year: 2020 ident: bib0055 article-title: Phosphoglycerate kinase 1 (PGK1) in cancer: a promising target for diagnosis and therapy publication-title: Life Sci. – volume: 50 start-page: 445 year: 2018 end-page: 460 ident: bib0009 article-title: Ferroptosis: a novel anti-tumor action for cisplatin publication-title: Cancer Res. Treat. – volume: 11 start-page: 3698 year: 2022 end-page: 3710 ident: bib0076 article-title: Bidirectional regulation between tumor cell-intrinsic PD-L1 and TGF-beta1 in epithelial-to-mesenchymal transition in melanoma publication-title: Transl. Cancer Res. – start-page: 10 year: 2023 ident: bib0043 article-title: Ferroptosis-related genes in cervical cancer as biomarkers for predicting the prognosis of gynecological tumors publication-title: Front. Mol. Biosci. – volume: 13 start-page: 445 year: 2018 end-page: 457 ident: bib0006 article-title: Rational design for cervical cancer therapeutics: cellular and non-cellular based strategies on the horizon for recurrent, metastatic or refractory cervical cancer publication-title: Expert. Opin. Drug Discov. – volume: 12 start-page: 836 year: 2021 end-page: 857 ident: bib0022 article-title: Ferroptosis, radiotherapy, and combination therapeutic strategies publication-title: Protein. Cell – volume: 16 start-page: 703 year: 2024 end-page: 710 ident: bib0057 article-title: DSG2 and c-MYC interact to regulate the expression of ADAM17 and promote the development of cervical cancer publication-title: Cancer Manage Res. – volume: 21 start-page: 95 year: 2020 ident: bib0007 article-title: The potential of immune checkpoint blockade in cervical cancer: can combinatorial regimens maximize response? A review of the literature publication-title: Curr. Treat. Options. Oncol. – volume: 14 start-page: 616 year: 2019 end-page: 622 ident: bib0011 article-title: FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels publication-title: Nat. Nanotechnol. – volume: 230 start-page: 806 year: 2015 end-page: 812 ident: bib0047 article-title: Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes publication-title: J. Cell Physiol. – volume: 7 start-page: 283ra53 year: 2015 ident: bib0027 article-title: Personalized genomic analyses for cancer mutation discovery and interpretation publication-title: Sci. Transl. Med. – volume: 8 start-page: 1347 year: 2020 ident: bib0008 article-title: The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer publication-title: Ann. Transl. Med. – volume: 35 start-page: 830 year: 2019 end-page: 849 ident: bib0023 article-title: Targeting ferroptosis to iron out cancer publication-title: Cancer. Cell – volume: 379 start-page: 1591 year: 2012 end-page: 1601 ident: bib0035 article-title: Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials publication-title: Lancet – volume: 7 start-page: e2307 year: 2016 ident: bib0010 article-title: Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells publication-title: Cell Death. Dis. – volume: 33 start-page: 100 year: 2021 end-page: 101 ident: bib0025 article-title: Genomics of aging: decreased immune defenses publication-title: J. Am. Assoc. Nurse Pr. – start-page: 30 year: 2024 ident: bib0049 article-title: RON receptor tyrosine kinase regulates glycolysis through MAPK/CREB signaling to affect ferroptosis and chemotherapy sensitivity of thyroid cancer cells publication-title: Mol. Med. Rep. – volume: 135 start-page: 584 year: 2022 end-page: 590 ident: bib0038 article-title: Cancer statistics in China and United States, 2022: profiles, trends, and determinants publication-title: Chin. Med. J. – volume: 18 start-page: 248 year: 2017 end-page: 262 ident: bib0081 article-title: Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade publication-title: Cell Rep. – volume: 10 year: 2022 ident: bib0044 article-title: Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer publication-title: Ann. Transl. Med. – volume: 27 start-page: e43 year: 2016 ident: bib0039 article-title: Advances in diagnosis and treatment of metastatic cervical cancer publication-title: J. Gynecol. Oncol. – volume: 13 start-page: 205 year: 2013 end-page: 220 ident: bib0004 article-title: Current and potential treatments for cervical cancer publication-title: Curr. Cancer Drug Targets. – volume: 112 start-page: 229 year: 2020 end-page: 232 ident: bib0064 article-title: A review of cervical cancer: incidence and disparities publication-title: J. Natl. Med. Assoc. – volume: 5 year: 2024 ident: bib0071 article-title: Chemoradiotherapy-induced ACKR2(+) tumor cells drive CD8(+) T cell senescence and cervical cancer recurrence publication-title: Cell Rep. Med. – volume: 10 year: 2023 ident: bib0021 article-title: Radiotherapy-induced ferroptosis for cancer treatment publication-title: Front. Mol. Biosci. – volume: 395 start-page: 1855 year: 2020 end-page: 1863 ident: bib0036 article-title: Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial publication-title: Lancet – volume: 15 start-page: 170 year: 2024 ident: bib0053 article-title: PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis publication-title: Cell Death. Dis. – volume: 520 start-page: 57 year: 2015 end-page: 62 ident: bib0015 article-title: Ferroptosis as a p53-mediated activity during tumour suppression publication-title: Nature – volume: 2017 year: 2017 ident: bib0048 article-title: Cervical carcinogenesis and immune response gene polymorphisms: a review publication-title: J. Immunol. Res. – volume: 235 start-page: 3425 year: 2020 end-page: 3437 ident: bib0020 article-title: Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin publication-title: J. Cell Physiol. – volume: 6 start-page: 23 year: 2020 ident: bib0069 article-title: The acute effects of adjuvant radiation and chemotherapy on peripheral blood epigenetic age in early stage breast cancer patients publication-title: NPJ. Breast. Cancer – volume: 68 start-page: 870 year: 2008 end-page: 879 ident: bib0070 article-title: Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion publication-title: Cancer Res. – start-page: 10 year: 2023 ident: bib0050 article-title: NAT10/ac4C/FOXP1 Promotes malignant progression and facilitates immunosuppression by reprogramming glycolytic metabolism in cervical cancer publication-title: Adv. Sci. – volume: 9 start-page: 4809 year: 2018 ident: bib0065 article-title: A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity publication-title: Nat. Commun. – volume: 327 start-page: 656 year: 2010 end-page: 661 ident: bib0074 article-title: Development of monocytes, macrophages, and dendritic cells publication-title: Science – volume: 185 start-page: 2401 year: 2022 end-page: 2421 ident: bib0014 article-title: Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications publication-title: Cell – volume: 23 start-page: 27 year: 2016 end-page: 47 ident: bib0059 article-title: The emerging hallmarks of cancer metabolism publication-title: Cell Metab. – volume: 110 start-page: 310 year: 2019 end-page: 320 ident: bib0073 article-title: PD-L1 expression enhancement by infiltrating macrophage-derived tumor necrosis factor-alpha leads to poor pancreatic cancer prognosis publication-title: Cancer Sci. – volume: 13 start-page: 118 year: 2022 ident: bib0054 article-title: PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis publication-title: Cell Death. Dis. – volume: 63 start-page: 173 year: 2016 end-page: 184 ident: bib0013 article-title: Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells publication-title: Hepatology – volume: 24 start-page: 1550 year: 2018 end-page: 1558 ident: bib0080 article-title: Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response publication-title: Nat. Med. – volume: 9 start-page: eadd8977 year: 2023 ident: bib0037 article-title: Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression publication-title: Sci. Adv. – volume: 20 start-page: 206 year: 2020 ident: bib0056 article-title: DSG2 expression is correlated with poor prognosis and promotes early-stage cervical cancer publication-title: Cancer Cell Int. – reference: <a cellular senescence related genes source aging albany ny so 2023.pdf>. – volume: 441 start-page: 431 year: 2006 end-page: 436 ident: bib0034 article-title: Nuclear factor-kappaB in cancer development and progression publication-title: Nature – volume: 17 start-page: 218 year: 2016 ident: bib0079 article-title: Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression publication-title: Genome Biol. – volume: 28 start-page: 671 year: 2021 end-page: 684 ident: bib0005 article-title: UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance publication-title: Cell Death. Differ. – volume: 22 start-page: 209 year: 2022 end-page: 223 ident: bib0067 article-title: CD8(+) T cell differentiation and dysfunction in cancer publication-title: Nat. Rev. Immunol. – volume: 19 start-page: 405 year: 2019 end-page: 414 ident: bib0018 article-title: Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion publication-title: Nat. Rev. Cancer – volume: 23 start-page: 222 year: 2021 end-page: 228 ident: bib0062 article-title: CDKN2A inhibits cell proliferation and invasion in cervical cancer through LDHA-mediated AKT/mTOR pathway publication-title: Clin. Transl. Oncol. – volume: 14 start-page: 49 year: 2021 ident: bib0041 article-title: A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma publication-title: BMC Med Genom. – volume: 8 year: 2018 ident: bib0019 article-title: KRAS: the critical driver and therapeutic target for pancreatic cancer publication-title: Cold. Spring. Harb. Perspect. Med. – start-page: 20 year: 2019 ident: bib0068 article-title: TGF-β signaling in cellular senescence and aging-related pathology publication-title: Int. J. Mol. Sci. – volume: 21 start-page: 47 year: 2022 ident: bib0017 article-title: Ferroptosis in cancer therapy: a novel approach to reversing drug resistance publication-title: Mol. Cancer – start-page: 122 year: 2024 ident: bib0016 article-title: Matrine induces ferroptosis in cervical cancer through activation of piezo1 channel publication-title: Phytomedicine – volume: 19 start-page: 10 year: 2018 end-page: 19 ident: bib0029 article-title: The twilight of immunity: emerging concepts in aging of the immune system publication-title: Nat. Immunol. – volume: 36 start-page: 336 year: 2020 end-page: 343 ident: bib0058 article-title: Significance of desmoglein-2 on cell malignant behaviors via mediating MAPK signaling in cervical cancer publication-title: Kaohsiung. J. Med. Sci. – volume: 115 start-page: E4041 year: 2018 end-page: E4050 ident: bib0075 article-title: Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment publication-title: Proc. Natl. Acad. Sci. U S A – volume: 163 start-page: 274 year: 2021 end-page: 280 ident: bib0066 article-title: Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer publication-title: Gynecol. Oncol. – volume: 11 start-page: 36 year: 2020 ident: bib0052 article-title: O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth publication-title: Nat. Commun. – volume: 138 start-page: 457 year: 2015 end-page: 471 ident: bib0003 article-title: Robotic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis publication-title: Gynecol. Oncol. – volume: 3 start-page: 991 year: 2002 end-page: 998 ident: bib0030 article-title: Cancer immunoediting: from immunosurveillance to tumor escape publication-title: Nat. Immunol. – reference: Cohen, P.A., A. Jhingran, A. Oaknin, et al., Cerv. Cancer. Lancet, 2019. 393(10167): p. 169–182. – start-page: 112 year: 2022 ident: bib0045 article-title: Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma publication-title: Int. Immunopharmacol. – volume: 113 start-page: 1018 year: 2021 end-page: 1028 ident: bib0042 article-title: Predicting DNA methylation from genetic data lacking racial diversity using shared classified random effects publication-title: Genomics – volume: 144 start-page: 646 year: 2011 end-page: 674 ident: bib0032 article-title: Hallmarks of cancer: the next generation publication-title: Cell – volume: 24 year: 2023 ident: bib0051 article-title: Modulating glycolysis to improve cancer therapy publication-title: Int. J. Mol. Sci. – start-page: 10 issue: 32 year: 2023 ident: 10.1016/j.tranon.2025.102487_bib0050 article-title: NAT10/ac4C/FOXP1 Promotes malignant progression and facilitates immunosuppression by reprogramming glycolytic metabolism in cervical cancer publication-title: Adv. Sci. – volume: 8 start-page: 1347 issue: 21 year: 2020 ident: 10.1016/j.tranon.2025.102487_bib0008 article-title: The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer publication-title: Ann. Transl. Med. doi: 10.21037/atm-20-2554a – volume: 7 start-page: 283ra53 issue: 283 year: 2015 ident: 10.1016/j.tranon.2025.102487_bib0027 article-title: Personalized genomic analyses for cancer mutation discovery and interpretation publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aaa7161 – volume: 23 start-page: 222 issue: 2 year: 2021 ident: 10.1016/j.tranon.2025.102487_bib0062 article-title: CDKN2A inhibits cell proliferation and invasion in cervical cancer through LDHA-mediated AKT/mTOR pathway publication-title: Clin. Transl. Oncol. doi: 10.1007/s12094-020-02409-4 – volume: 16 issue: 4 year: 2024 ident: 10.1016/j.tranon.2025.102487_bib0028 article-title: Magnesium and the hallmarks of aging publication-title: Nutrients. doi: 10.3390/nu16040496 – volume: 107 start-page: 129 year: 2019 ident: 10.1016/j.tranon.2025.102487_bib0061 article-title: Proteomic characterization of early lung response to breast cancer metastasis in mice publication-title: Exp. Mol. Pathol. doi: 10.1016/j.yexmp.2019.02.001 – start-page: 112 year: 2022 ident: 10.1016/j.tranon.2025.102487_bib0045 article-title: Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma publication-title: Int. Immunopharmacol. – volume: 2017 year: 2017 ident: 10.1016/j.tranon.2025.102487_bib0048 article-title: Cervical carcinogenesis and immune response gene polymorphisms: a review publication-title: J. Immunol. Res. doi: 10.1155/2017/8913860 – volume: 10 issue: 2 year: 2022 ident: 10.1016/j.tranon.2025.102487_bib0044 article-title: Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer publication-title: Ann. Transl. Med. doi: 10.21037/atm-21-6265 – volume: 16 start-page: 703 year: 2024 ident: 10.1016/j.tranon.2025.102487_bib0057 article-title: DSG2 and c-MYC interact to regulate the expression of ADAM17 and promote the development of cervical cancer publication-title: Cancer Manage Res. doi: 10.2147/CMAR.S456548 – volume: 127 year: 2020 ident: 10.1016/j.tranon.2025.102487_bib0026 article-title: The emerging role of ferroptosis in inflammation publication-title: Biomed. PharmacOther doi: 10.1016/j.biopha.2020.110108 – volume: 163 start-page: 274 issue: 2 year: 2021 ident: 10.1016/j.tranon.2025.102487_bib0066 article-title: Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2021.08.018 – volume: 3 start-page: 991 issue: 11 year: 2002 ident: 10.1016/j.tranon.2025.102487_bib0030 article-title: Cancer immunoediting: from immunosurveillance to tumor escape publication-title: Nat. Immunol. doi: 10.1038/ni1102-991 – volume: 520 start-page: 57 issue: 7545 year: 2015 ident: 10.1016/j.tranon.2025.102487_bib0015 article-title: Ferroptosis as a p53-mediated activity during tumour suppression publication-title: Nature doi: 10.1038/nature14344 – volume: 13 start-page: 205 issue: 2 year: 2013 ident: 10.1016/j.tranon.2025.102487_bib0004 article-title: Current and potential treatments for cervical cancer publication-title: Curr. Cancer Drug Targets. doi: 10.2174/1568009611313020009 – volume: 10 year: 2023 ident: 10.1016/j.tranon.2025.102487_bib0021 article-title: Radiotherapy-induced ferroptosis for cancer treatment publication-title: Front. Mol. Biosci. doi: 10.3389/fmolb.2023.1216733 – volume: 441 start-page: 431 issue: 7092 year: 2006 ident: 10.1016/j.tranon.2025.102487_bib0034 article-title: Nuclear factor-kappaB in cancer development and progression publication-title: Nature doi: 10.1038/nature04870 – volume: 113 start-page: 1018 issue: 1 Pt 2 year: 2021 ident: 10.1016/j.tranon.2025.102487_bib0042 article-title: Predicting DNA methylation from genetic data lacking racial diversity using shared classified random effects publication-title: Genomics doi: 10.1016/j.ygeno.2020.10.036 – volume: 21 start-page: 95 issue: 12 year: 2020 ident: 10.1016/j.tranon.2025.102487_bib0007 article-title: The potential of immune checkpoint blockade in cervical cancer: can combinatorial regimens maximize response? A review of the literature publication-title: Curr. Treat. Options. Oncol. doi: 10.1007/s11864-020-00790-4 – volume: 47 issue: 4 year: 2022 ident: 10.1016/j.tranon.2025.102487_bib0063 article-title: Inhibition of LDHA suppresses cell proliferation and increases mitochondrial apoptosis via the JNK signaling pathway in cervical cancer cells publication-title: Oncol. Rep. doi: 10.3892/or.2022.8288 – start-page: 30 issue: 6 year: 2024 ident: 10.1016/j.tranon.2025.102487_bib0049 article-title: RON receptor tyrosine kinase regulates glycolysis through MAPK/CREB signaling to affect ferroptosis and chemotherapy sensitivity of thyroid cancer cells publication-title: Mol. Med. Rep. – ident: 10.1016/j.tranon.2025.102487_bib0001 doi: 10.1016/S0140-6736(18)32470-X – volume: 27 start-page: e43 issue: 4 year: 2016 ident: 10.1016/j.tranon.2025.102487_bib0039 article-title: Advances in diagnosis and treatment of metastatic cervical cancer publication-title: J. Gynecol. Oncol. doi: 10.3802/jgo.2016.27.e43 – volume: 112 start-page: 229 issue: 2 year: 2020 ident: 10.1016/j.tranon.2025.102487_bib0064 article-title: A review of cervical cancer: incidence and disparities publication-title: J. Natl. Med. Assoc. – volume: 21 start-page: 182 issue: 1 year: 2021 ident: 10.1016/j.tranon.2025.102487_bib0040 article-title: Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis publication-title: Cancer Cell Int. doi: 10.1186/s12935-021-01867-2 – volume: 63 start-page: 173 issue: 1 year: 2016 ident: 10.1016/j.tranon.2025.102487_bib0013 article-title: Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells publication-title: Hepatology doi: 10.1002/hep.28251 – volume: 144 start-page: 646 issue: 5 year: 2011 ident: 10.1016/j.tranon.2025.102487_bib0032 article-title: Hallmarks of cancer: the next generation publication-title: Cell doi: 10.1016/j.cell.2011.02.013 – volume: 14 start-page: 49 issue: 1 year: 2021 ident: 10.1016/j.tranon.2025.102487_bib0041 article-title: A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma publication-title: BMC Med Genom. doi: 10.1186/s12920-021-00885-3 – volume: 19 start-page: 10 issue: 1 year: 2018 ident: 10.1016/j.tranon.2025.102487_bib0029 article-title: The twilight of immunity: emerging concepts in aging of the immune system publication-title: Nat. Immunol. doi: 10.1038/s41590-017-0006-x – volume: 11 start-page: 36 issue: 1 year: 2020 ident: 10.1016/j.tranon.2025.102487_bib0052 article-title: O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth publication-title: Nat. Commun. doi: 10.1038/s41467-019-13601-8 – volume: 23 start-page: 27 issue: 1 year: 2016 ident: 10.1016/j.tranon.2025.102487_bib0059 article-title: The emerging hallmarks of cancer metabolism publication-title: Cell Metab. doi: 10.1016/j.cmet.2015.12.006 – volume: 42 start-page: 513 issue: 4 year: 2016 ident: 10.1016/j.tranon.2025.102487_bib0002 article-title: Robot-assisted versus open radical hysterectomy: a multi-institutional experience for early-stage cervical cancer publication-title: Eur. J. Surg. Oncol. doi: 10.1016/j.ejso.2015.12.014 – volume: 22 start-page: 209 issue: 4 year: 2022 ident: 10.1016/j.tranon.2025.102487_bib0067 article-title: CD8(+) T cell differentiation and dysfunction in cancer publication-title: Nat. Rev. Immunol. doi: 10.1038/s41577-021-00574-3 – volume: 230 start-page: 806 issue: 4 year: 2015 ident: 10.1016/j.tranon.2025.102487_bib0047 article-title: Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes publication-title: J. Cell Physiol. doi: 10.1002/jcp.24808 – volume: 115 start-page: E4041 issue: 17 year: 2018 ident: 10.1016/j.tranon.2025.102487_bib0075 article-title: Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment publication-title: Proc. Natl. Acad. Sci. U S A doi: 10.1073/pnas.1720948115 – volume: 256 year: 2020 ident: 10.1016/j.tranon.2025.102487_bib0055 article-title: Phosphoglycerate kinase 1 (PGK1) in cancer: a promising target for diagnosis and therapy publication-title: Life Sci. doi: 10.1016/j.lfs.2020.117863 – volume: 11 start-page: 3698 issue: 10 year: 2022 ident: 10.1016/j.tranon.2025.102487_bib0076 article-title: Bidirectional regulation between tumor cell-intrinsic PD-L1 and TGF-beta1 in epithelial-to-mesenchymal transition in melanoma publication-title: Transl. Cancer Res. doi: 10.21037/tcr-22-292 – volume: 36 start-page: 336 issue: 5 year: 2020 ident: 10.1016/j.tranon.2025.102487_bib0058 article-title: Significance of desmoglein-2 on cell malignant behaviors via mediating MAPK signaling in cervical cancer publication-title: Kaohsiung. J. Med. Sci. doi: 10.1002/kjm2.12182 – volume: 235 start-page: 3425 issue: 4 year: 2020 ident: 10.1016/j.tranon.2025.102487_bib0020 article-title: Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin publication-title: J. Cell Physiol. doi: 10.1002/jcp.29232 – volume: 9 start-page: eadd8977 issue: 4 year: 2023 ident: 10.1016/j.tranon.2025.102487_bib0037 article-title: Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression publication-title: Sci. Adv. doi: 10.1126/sciadv.add8977 – volume: 6 start-page: 23 year: 2020 ident: 10.1016/j.tranon.2025.102487_bib0069 article-title: The acute effects of adjuvant radiation and chemotherapy on peripheral blood epigenetic age in early stage breast cancer patients publication-title: NPJ. Breast. Cancer doi: 10.1038/s41523-020-0161-3 – start-page: 122 year: 2024 ident: 10.1016/j.tranon.2025.102487_bib0016 article-title: Matrine induces ferroptosis in cervical cancer through activation of piezo1 channel publication-title: Phytomedicine – volume: 13 start-page: 118 issue: 2 year: 2022 ident: 10.1016/j.tranon.2025.102487_bib0054 article-title: PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis publication-title: Cell Death. Dis. doi: 10.1038/s41419-022-04576-4 – volume: 18 start-page: 248 issue: 1 year: 2017 ident: 10.1016/j.tranon.2025.102487_bib0081 article-title: Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade publication-title: Cell Rep. doi: 10.1016/j.celrep.2016.12.019 – volume: 28 start-page: 671 issue: 2 year: 2021 ident: 10.1016/j.tranon.2025.102487_bib0005 article-title: UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance publication-title: Cell Death. Differ. doi: 10.1038/s41418-020-00616-8 – volume: 9 start-page: 4809 issue: 1 year: 2018 ident: 10.1016/j.tranon.2025.102487_bib0065 article-title: A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity publication-title: Nat. Commun. doi: 10.1038/s41467-018-07195-w – volume: 327 start-page: 656 issue: 5966 year: 2010 ident: 10.1016/j.tranon.2025.102487_bib0074 article-title: Development of monocytes, macrophages, and dendritic cells publication-title: Science doi: 10.1126/science.1178331 – volume: 15 start-page: 170 issue: 2 year: 2024 ident: 10.1016/j.tranon.2025.102487_bib0053 article-title: PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis publication-title: Cell Death. Dis. doi: 10.1038/s41419-024-06544-6 – volume: 357 start-page: 539 issue: 9255 year: 2001 ident: 10.1016/j.tranon.2025.102487_bib0033 article-title: Inflammation and cancer: back to Virchow? publication-title: Lancet doi: 10.1016/S0140-6736(00)04046-0 – volume: 185 start-page: 2401 issue: 14 year: 2022 ident: 10.1016/j.tranon.2025.102487_bib0014 article-title: Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications publication-title: Cell doi: 10.1016/j.cell.2022.06.003 – volume: 12 start-page: 836 issue: 11 year: 2021 ident: 10.1016/j.tranon.2025.102487_bib0022 article-title: Ferroptosis, radiotherapy, and combination therapeutic strategies publication-title: Protein. Cell doi: 10.1007/s13238-021-00841-y – volume: 331 start-page: 1565 issue: 6024 year: 2011 ident: 10.1016/j.tranon.2025.102487_bib0031 article-title: Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion publication-title: Science doi: 10.1126/science.1203486 – volume: 110 start-page: 310 issue: 1 year: 2019 ident: 10.1016/j.tranon.2025.102487_bib0073 article-title: PD-L1 expression enhancement by infiltrating macrophage-derived tumor necrosis factor-alpha leads to poor pancreatic cancer prognosis publication-title: Cancer Sci. doi: 10.1111/cas.13874 – start-page: 10 issue: 10 year: 2022 ident: 10.1016/j.tranon.2025.102487_bib0072 article-title: Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy publication-title: J. ImmunOther Cancer – volume: 14 start-page: 616 issue: 6 year: 2019 ident: 10.1016/j.tranon.2025.102487_bib0011 article-title: FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels publication-title: Nat. Nanotechnol. doi: 10.1038/s41565-019-0406-1 – volume: 135 start-page: 584 issue: 5 year: 2022 ident: 10.1016/j.tranon.2025.102487_bib0038 article-title: Cancer statistics in China and United States, 2022: profiles, trends, and determinants publication-title: Chin. Med. J. doi: 10.1097/CM9.0000000000002108 – volume: 138 start-page: 457 issue: 2 year: 2015 ident: 10.1016/j.tranon.2025.102487_bib0003 article-title: Robotic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2015.06.009 – volume: 24 issue: 3 year: 2023 ident: 10.1016/j.tranon.2025.102487_bib0051 article-title: Modulating glycolysis to improve cancer therapy publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms24032606 – volume: 7 start-page: e2307 issue: 7 year: 2016 ident: 10.1016/j.tranon.2025.102487_bib0010 article-title: Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells publication-title: Cell Death. Dis. doi: 10.1038/cddis.2016.208 – volume: 13 start-page: 445 issue: 5 year: 2018 ident: 10.1016/j.tranon.2025.102487_bib0006 article-title: Rational design for cervical cancer therapeutics: cellular and non-cellular based strategies on the horizon for recurrent, metastatic or refractory cervical cancer publication-title: Expert. Opin. Drug Discov. doi: 10.1080/17460441.2018.1443074 – volume: 5 issue: 5 year: 2024 ident: 10.1016/j.tranon.2025.102487_bib0071 article-title: Chemoradiotherapy-induced ACKR2(+) tumor cells drive CD8(+) T cell senescence and cervical cancer recurrence publication-title: Cell Rep. Med. – volume: 50 start-page: 445 issue: 2 year: 2018 ident: 10.1016/j.tranon.2025.102487_bib0009 article-title: Ferroptosis: a novel anti-tumor action for cisplatin publication-title: Cancer Res. Treat. doi: 10.4143/crt.2016.572 – volume: 52 start-page: 1011 issue: 3 year: 2018 ident: 10.1016/j.tranon.2025.102487_bib0012 article-title: Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis publication-title: Int. J. Oncol. – ident: 10.1016/j.tranon.2025.102487_bib0046 – volume: 35 start-page: 830 issue: 6 year: 2019 ident: 10.1016/j.tranon.2025.102487_bib0023 article-title: Targeting ferroptosis to iron out cancer publication-title: Cancer. Cell doi: 10.1016/j.ccell.2019.04.002 – volume: 379 start-page: 1591 issue: 9826 year: 2012 ident: 10.1016/j.tranon.2025.102487_bib0035 article-title: Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials publication-title: Lancet doi: 10.1016/S0140-6736(12)60209-8 – start-page: 10 year: 2023 ident: 10.1016/j.tranon.2025.102487_bib0043 article-title: Ferroptosis-related genes in cervical cancer as biomarkers for predicting the prognosis of gynecological tumors publication-title: Front. Mol. Biosci. – volume: 68 start-page: 870 issue: 3 year: 2008 ident: 10.1016/j.tranon.2025.102487_bib0070 article-title: Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-07-2282 – volume: 395 start-page: 1855 issue: 10240 year: 2020 ident: 10.1016/j.tranon.2025.102487_bib0036 article-title: Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(20)30366-4 – volume: 20 start-page: 206 year: 2020 ident: 10.1016/j.tranon.2025.102487_bib0056 article-title: DSG2 expression is correlated with poor prognosis and promotes early-stage cervical cancer publication-title: Cancer Cell Int. doi: 10.1186/s12935-020-01292-x – ident: 10.1016/j.tranon.2025.102487_bib0060 doi: 10.1097/01.mpa.0000153326.69816.7d – volume: 17 start-page: 218 issue: 1 year: 2016 ident: 10.1016/j.tranon.2025.102487_bib0079 article-title: Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression publication-title: Genome Biol. doi: 10.1186/s13059-016-1070-5 – volume: 8 issue: 9 year: 2018 ident: 10.1016/j.tranon.2025.102487_bib0019 article-title: KRAS: the critical driver and therapeutic target for pancreatic cancer publication-title: Cold. Spring. Harb. Perspect. Med. doi: 10.1101/cshperspect.a031435 – volume: 19 start-page: 405 issue: 7 year: 2019 ident: 10.1016/j.tranon.2025.102487_bib0018 article-title: Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-019-0149-1 – volume: 33 start-page: 100 issue: 2 year: 2021 ident: 10.1016/j.tranon.2025.102487_bib0025 article-title: Genomics of aging: decreased immune defenses publication-title: J. Am. Assoc. Nurse Pr. doi: 10.1097/JXX.0000000000000579 – ident: 10.1016/j.tranon.2025.102487_bib0077 – volume: 21 start-page: 47 issue: 1 year: 2022 ident: 10.1016/j.tranon.2025.102487_bib0017 article-title: Ferroptosis in cancer therapy: a novel approach to reversing drug resistance publication-title: Mol. Cancer doi: 10.1186/s12943-022-01530-y – volume: 13 start-page: 757 year: 2018 ident: 10.1016/j.tranon.2025.102487_bib0024 article-title: Oxidative stress, aging, and diseases publication-title: Clin. Interv. Aging doi: 10.2147/CIA.S158513 – start-page: 20 issue: 20 year: 2019 ident: 10.1016/j.tranon.2025.102487_bib0068 article-title: TGF-β signaling in cellular senescence and aging-related pathology publication-title: Int. J. Mol. Sci. – volume: 24 start-page: 1550 issue: 10 year: 2018 ident: 10.1016/j.tranon.2025.102487_bib0080 article-title: Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response publication-title: Nat. Med. doi: 10.1038/s41591-018-0136-1 – volume: 69 start-page: 2477 issue: 12 year: 2020 ident: 10.1016/j.tranon.2025.102487_bib0078 article-title: The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer publication-title: Cancer Immunol. Immunther. doi: 10.1007/s00262-020-02628-2 |
| SSID | ssj0061922 |
| Score | 2.3741238 |
| Snippet | •Ferroptosis and aging have serious effects on human tumors.•The GSVA scores of ferroptosis and aging are upregulated in cervical cancer tissues.•Ferroptosis... Mortality and treatment failure in cervical cancer (CC) patients are primarily due to extensive metastasis and chemoresistance. Immunotherapy has emerged as a... • Ferroptosis and aging have serious effects on human tumors. • The GSVA scores of ferroptosis and aging are upregulated in cervical cancer tissues. •... |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 102487 |
| SubjectTerms | Cellular senescence Cervical cancer Ferroptosis Immunotherapy Original Research |
| SummonAdditionalLinks | – databaseName: ScienceDirect Free and Delayed Access Titles dbid: IXB link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JjtQwELVGc0BcEDthk5G4Wp2OlyTcmBatAWngMIzUN8srBEHSSno-gr-myklaEziAuGX3UpVa4novhLxGJ1dzI5goc8OEN4pVRkpWGNiuhPPOpgLZj-r8SnzYyd0J2cxYGCyrnGz_aNOTtZ6OrKbZXO2bZnUJoYeCNIqDE0dHhSA-LqoE4tudzdYY84NiXFlWmHTxGT6XarwO4A86ZEEtJHIYCCysu-GeEov_wkv9GYX-Xkx5wztt75I7U1hJ3449v0dOQnuf3LqYFs4fkJ_b0Pfd_tANzUBN6yl-sMcKVDqgsXM4bspSZVzwFLmoB9q0dJMsCTx4g8rRv6EXAZHCidyZvm8HzOwHihAVmpC87NOPxo0NTISj3-mlQQJiOrOfPCRX23efN-ds-gsDc0LUJbNWWudiEXMZwZtHx62NCty8dBCeFIWRcNY45WTMTR18UAFSIFvYKqyF5Z4_IqcwyeEJoT5w7tY1XO2iiGU0EL2F3LlS-FrYdZkRNk--3o9kG3quQvumR2FpFJYehZWRM5TQ8Vqkyk4Huv6LnnRFQ5M2qNp5GwPi_k0sQ-ktpJpeqLysMyJn-eoZjQr2Ex7U_KXx8njfQmP_4c5XsxppeJlR4KYN3fWgOQRQkA9WqsrI41GtjoPDBVdR5Coj1ULhFqNfnmmbr4kwHPHQZaHqp__d5WfkNu6NVYzPyemhvw4vIBo72JfpdfsFWLI3Lg priority: 102 providerName: Elsevier |
| Title | Ferroptosis and cellular senescence -Related Genes in Cervical Cancer: Mechanistic Insights from Multi-Omics and Clinical Sample Analysis |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1936523325002189 https://dx.doi.org/10.1016/j.tranon.2025.102487 https://www.ncbi.nlm.nih.gov/pubmed/40784206 https://www.proquest.com/docview/3238428868 https://pubmed.ncbi.nlm.nih.gov/PMC12357269 https://doaj.org/article/33cbe69cdbfe4316af7e7db282d46079 |
| Volume | 60 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQHhAXxJvwkpG4WqSOHwk3tqLaRVo4wEq9WX6KIEhXTfdH8K-ZsZOqhcNy4BJFSZzEnvE8km8-E_IGnVzXWMGEri0TwSrWWikZt7DfCh-8ywDZT-rsUnxcy_XBUl-ICSv0wGXg3jaNd1F1PrgUsWzbJh11cJApBKFqnUv3wOfNyVSxwZgV8LlQLqO5dmD5N8h3yiWyFQiE0B04oszXf-SP_o43_4RNHvih1T1ydwog6fvy4vfJrTg8ILcvpl_kD8mvVdxuN1e7zdiP1A6B4qd5xJrSEc2ax5lMWcbAxUCRdXqk_UCX2WbAjZeoBtt39CJiTXCmcabnw4g5_EixGIXmml32-WfvywMmatEf9ItFqmE685w8IperD1-XZ2xab4F5ITrNnJPO-8RTLRP47eQb55IChy49BCKcWwlnrVdeptp2MUQVIdlx3LVxIVwTmsfkBAY5PiU0RJDbooOrfRJJJwtxWqy91yJ0wi10Rdg8-Oaq0GqYGW_23RRhGRSWKcKqyClKaH8tkmLnA6AqZlIVc5OqVETO8jVz3SlYSrhRf8PD9b7dFJeUeOMfWr6e1cjAtEWB2yFurkfTQKgEmV-r2oo8KWq17xz-WhW8VhVpjxTuqPfHZ4b-W6YGx8pnzVX37H-M13NyB_tSoIsvyMluex1fQgi2c6_ybIPt-fr0N-z2NhM |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj5RAEO6sa6JejG_x2SZeyTDQdIM3d-JkRnfWw-4mc-v0UzEKE5j9Ef5rqxqYLHrQeCM00I8q6quiqz4IeYsgV2aKxUwkKmZW8bhQeR6nCo4LZqzRIUH2jK8u2cdtvj0ii7EWBtMqB9vf2_RgrYczs2E1Z7uqmp2D68EhjMoAxBGoyhvkJngDAv_fsN6ejOYYA4S031rmGHVlY_1cSPLaAyA0SIOa5khiwDCz7ho-BRr_CUz96Yb-nk15DZ6W98jdwa-k7_uh3ydHrn5Abm2GnfOH5OfStW2z2zdd1VFVW4pf7DEFlXZo7QxOnMYhNc5ZimTUHa1qugimBB68QO1o39GNw1LhwO5M13WHoX1HsUaFhlLe-POPyvQdDIyj3-m5QgZiOtKfPCKXyw8Xi1U8_IYhNoyVItY618b41Ce5Bzj3JtPac8D53IB_kqYqh1ZluMl9okpnHXcQA-lUF27OdGazx-QYFtk9JdS6LDPzEq42nnnhFQjMJcYIZkum5yIi8bj4ctezbcgxDe2b7IUlUViyF1ZETlBCh2uRKzucaNovclAWCV1qx0tjtXdY-K-8cMJqiDUt44koI5KP8pVjOSoYUHhQ9ZfOxeG-icr-w51vRjWS8DajwFXtmqtOZuBBQUBY8CIiT3q1OkwOd1xZmvCIFBOFm8x-2lJXXwNjOBZEi5SXz_57yK_J7dXF5lSers8-PSd3sKVPaXxBjvftlXsJrtlevwqv3i_ttjpN |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ferroptosis+and+cellular+senescence+-Related+Genes+in+Cervical+Cancer%3A+Mechanistic+Insights+from+Multi-Omics+and+Clinical+Sample+Analysis&rft.jtitle=Translational+oncology&rft.au=Luo%2C+Yongjin&rft.au=Tang%2C+Lihua&rft.au=Zeng%2C+Zhonghong&rft.au=Trang%2C+DinhHuyen&rft.date=2025-10-01&rft.pub=Neoplasia+Press&rft.eissn=1936-5233&rft.volume=60&rft_id=info:doi/10.1016%2Fj.tranon.2025.102487&rft_id=info%3Apmid%2F40784206&rft.externalDocID=PMC12357269 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1936-5233&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1936-5233&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1936-5233&client=summon |